NSE: BALAMINES | BSE: 530999

Mid-range Performer

Download real time

1448.90 17.50 (1.22%)

43.17% Fall from 52W High

50,927 NSE+BSE Volume

NSE 23 May, 2025 3:31 PM (IST)

4,694.6

Market Cap

Above industry Median

1.1

Beta 1Year

High Volatility

Board Meeting

The next board meeting for Balaji Amines Ltd. is on 26 May 2025 for the purpose of Audited Results & Final Dividend See details

Balaji Amines Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for BALAMINES, BSE:530999 Balaji Amines Ltd.

Search Inside the pdf :

Balaji Amines Ltd.

14 Feb 2025

1448.90

1.22%

Volume and pricing pressures weigh on performance

Accumulate: Balaji Amines Ltd.

Recommendation Target

KRChoksey

Balaji Amines’ revenue missed our estimates due to weak demand. EBITDA missed our estimates due to miss in the revenue and operating deleverage. Adj. PAT missed our estimates due to weak operating performance, higher than expected depreciation expense, and lower-than-expected other income.

Balaji Amines Ltd. is trading above its 50 day SMA of 1288.7

Balaji Amines Ltd.

20 Nov 2024

1448.90

1.22%

Positioned for long-term growth with high-margin focus and capacity expansion

Buy: Balaji Amines Ltd.

Target

KRChoksey

Balaji Amines’ revenue missed our estimates due to decline in price realization and volume. EBITDA missed our estimates due to miss in the revenue and operating deleverage.

Balaji Amines Ltd. has an average target of 1640.00 from 1 broker.

Balaji Amines Ltd.

09 Aug 2024

1448.90

1.22%

Lack of demand in agrochemical sector impacted the quarterly performance

Buy: Balaji Amines Ltd.

Target

KRChoksey

Balaji Amines missed our revenue estimate significantly due to a steep fall in the price realization. The EBITDA missed our estimates primarily due to a lower-than-expected revenue and higher-than-expected operating expenses.

Balaji Amines Ltd. is trading above its 50 day SMA of 1288.7

Balaji Amines Ltd.

21 May 2024

1448.90

1.22%

Pick-up in domestic demand drives sequential performance

Buy: Balaji Amines Ltd.

Recommendation Target

KRChoksey

Balaji Amines revenue beat our estimate by 4.5% due to strong volume growth in Amines and Amine derivatives. The EBITDA beat our estimate primarily due to a beat in revenue and lower-than-expected operating expenses.

Balaji Amines Ltd. is trading above its 50 day SMA of 1288.7

Balaji Amines Ltd.

26 Mar 2024

1448.90

1.22%

BALAJI AMINES LTD

Not Rated: Balaji Amines Ltd.

Prabhudas Lilladhar

Number of MF schemes decreased from 26 to 11 in Mar 2025 qtr

Balaji Amines Ltd.

20 Mar 2024

1448.90

1.22%

Balaji Amines Ltd.

Buy: Balaji Amines Ltd.

Target

CD Equisearch

Balaji Amines Ltd. has an average target of 1640.00 from 1 broker.

Balaji Amines Ltd.

22 Nov 2023

1448.90

1.22%

Significant drop in top line and profits due to multiple headwinds for the business

Accumulate: Balaji Amines Ltd.

Recommendation Target

KRChoksey

For Q2FY24, BLA revenue declined by 39.4% YoY and 17.9% QoQ to INR 3,805 Mn while for H1FY24 revenue declined by 34.9% YoY to INR 8,442 Mn. The sales volume reached 27,613 MT in Q2FY24 as against 28,498 MT in Q2FY23 and 26,820 MT in Q1FY24 which was a decline of 3.1% YoY and a slight increase of 3.0% QoQ. Amines volume stood at 8,092 MT which had a growth of 28.2% YoY and 19.8% QoQ.

Balaji Amines Ltd. has an average target of 1640.00 from 1 broker.

Balaji Amines Ltd.

30 May 2023

1448.90

1.22%

Balaji Amines Ltd.

Buy: Balaji Amines Ltd.

Target

CD Equisearch

Balaji Amines Ltd. has an average target of 1640.00 from 1 broker.

Balaji Amines Ltd.

25 May 2023

1448.90

1.22%

Ramp up in new capacities will drive volume growth

Buy: Balaji Amines Ltd.

Target

KRChoksey

The standalone revenue of the company experienced a significant decline, falling by 44% YoY and 16% QoQ, amounting to INR 3470 mn. This decline can be attributed to weak demand in the pharma, API, and agro industries, along with the volatility in key input prices such as ammonia, methanol, and acetic acid.